A glutamate/aspartate switch controls product specificity in a protein arginine methyltransferase

  • Erik W. Debler
    Laboratory of Cell Biology, The Rockefeller University, New York, NY 10065;
  • Kanishk Jain
    Department of Chemistry and Biochemistry and The Molecular Biology Institute, University of California, Los Angeles, CA 90095;
  • Rebeccah A. Warmack
    Department of Chemistry and Biochemistry and The Molecular Biology Institute, University of California, Los Angeles, CA 90095;
  • You Feng
    Department of Chemistry and Biochemistry and The Molecular Biology Institute, University of California, Los Angeles, CA 90095;
  • Steven G. Clarke
    Department of Chemistry and Biochemistry and The Molecular Biology Institute, University of California, Los Angeles, CA 90095;
  • Günter Blobel
    Laboratory of Cell Biology, The Rockefeller University, New York, NY 10065;
  • Pete Stavropoulos
    Laboratory of Cell Biology, The Rockefeller University, New York, NY 10065;

書誌事項

公開日
2016-02-08
権利情報
  • http://www.pnas.org/preview_site/misc/userlicense.xhtml
DOI
  • 10.1073/pnas.1525783113
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:title>Significance</jats:title> <jats:p> Posttranslational modifications in proteins profoundly modulate their function, and enzymes that generate these modifications therefore have key regulatory roles in a wide array of biological processes. Protein arginine methyltransferases (PRMTs) attach methyl group(s) to arginines and differ in their product specificity, as they form either monomethyl arginine (MMA), asymmetric dimethylarginine (ADMA), or symmetric dimethylarginine (SDMA), each of which relays specific biological signals. Although the members of the PRMT family are structurally highly homologous, the precise molecular basis of their product specificity has not been determined. Based on our structure of <jats:italic>Tb</jats:italic> PRMT7, which explicitly forms MMA, we identified a glutamate residue as a key determinant of its product specificity, and we were able to engineer a <jats:italic>Tb</jats:italic> PRMT7 mutant capable of ADMA formation. </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ